The concept of essential medicines: lessons for rich countries
- PMID: 15539676
- PMCID: PMC527702
- DOI: 10.1136/bmj.329.7475.1169
The concept of essential medicines: lessons for rich countries
Abstract
Rich countries should follow the lead of poor countries and adopt a more systematic way of controlling the cost of drugs
Figures
Comment in
-
The pros and cons of essential medicines for rich countries.BMJ. 2004 Nov 13;329(7475):1172. doi: 10.1136/bmj.329.7475.1172. BMJ. 2004. PMID: 15539677 Free PMC article. No abstract available.
-
Learning from low income countries: poor patients deserve more science and less advocacy.BMJ. 2005 Feb 26;330(7489):479; discussion 479. doi: 10.1136/bmj.330.7489.479. BMJ. 2005. PMID: 15731157 Free PMC article. No abstract available.
References
-
- World Health Organization. The selection and use of essential medicines. Report of the WHO Expert Committee, 2002 (including the 12th Model List of Essential Medicines). Technical Report Series No 914. Geneva: WHO, 2003. - PubMed
-
- World Health Organization. The selection and use of essential medicines. Report of the WHO Expert Committee, 2002 (including the 12th Model List of Essential Medicines). Technical Report Series No 914. Geneva: WHO, 2003: 15. - PubMed
-
- Grimshaw J, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993;342: 1317-22. - PubMed
-
- Kafuko J, Bagenda D. Impact of national standard treatment guidelines on rational drug use in Uganda health facilities. Kampala: Unicef/Uganda, 1994.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical